** Shares of drug developer Edesa Biotech EDSA.O surge 68.9% to $3.1 in morning trade
** EDSA says it is raising $15 million from private placement of shares
** Co says it will use the proceeds towards a mid-stage trial evaluating its experimental treatment EB06 in patients with nonsegmental vitiligo, a chronic skin disorder that causes patches and loss of skin color
** Co says shares were offered directly to the investors without a placement agent, underwriter, broker or dealer
** Co has 3.47 mln outstanding shares and market value of $6.45 mln - LSEG data
** Stock fell ~69% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.